Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

85.01 -4.37 (-4.89%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,424,328
Open 87.00
Bid (Size) 83.50 (1)
Ask (Size) 88.41 (3)
Prev. Close 89.38
Today's Range 81.82 - 92.97
52wk Range 2.850 - 98.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx Announces Preliminary 2024 Financial Results
From GeneDx
Via Business Wire
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers
From GeneDx
Via Business Wire

Performance

YTD
+6.76%
+6.76%
1 Month
+12.70%
+12.70%
3 Month
+42.28%
+42.28%
6 Month
+146.41%
+146.41%
1 Year
+2452.85%
+2452.85%

More News

Read More
I’m Not Worried About This Pullback
Via Talk Markets
Topics Cryptocurrencies Stocks / Equities
Why NASDAQ:WGS qualifies as a high growth stock.
Via Chartmill
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients
From GeneDx
Via Business Wire
IBD 50's GeneDx Surges On FDA Recommendations For AI Device Development
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Focus On High Cash Flow Companies. You Are The Company You Keep.
Via Talk Markets
Topics Stocks / Equities
Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly
Via Investor's Business Daily
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday
Via Benzinga
GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer
From GeneDx
Via Business Wire
Best Performing Stocks Of 2024
Via Talk Markets
Topics Stocks / Equities
The Top 5 Mid Cap Stocks Of 2024
Via Talk Markets
Topics Stocks / Equities
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From GeneDx
Via Business Wire
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners
From GeneDx
Via Business Wire
GeneDx to Participate in Upcoming Investor Conference
From GeneDx
Via Business Wire
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
From GeneDx
Via Business Wire
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
From GeneDx
Via Business Wire
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
Via The Motley Fool
Don’t Confuse Brains With A Bull Market, Or Price With Value
Via Talk Markets
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
From GeneDx
Via Business Wire
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
From GeneDx
Via Business Wire
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Via Benzinga
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.